Literature DB >> 17553243

Bartonella species in blood of immunocompetent persons with animal and arthropod contact.

Edward B Breitschwerdt1, Ricardo G Maggi, Ashlee W Duncan, William L Nicholson, Barbara C Hegarty, Christopher W Woods.   

Abstract

Using PCR in conjunction with pre-enrichment culture, we detected Bartonella henselae and B. vinsonii subspecies berkhoffii in the blood of 14 immunocompetent persons who had frequent animal contact and arthropod exposure.

Entities:  

Mesh:

Year:  2007        PMID: 17553243      PMCID: PMC2792845          DOI: 10.3201/eid1306.061337

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Attempts to isolate Bartonella sp. from immunocompetent persons with serologic, pathologic, or molecular evidence of infection are often unsuccessful; several investigators have indicated that Bartonella isolation methods need to be improved (–). By combining PCR and pre-enrichment culture, we detected B. henselae and B. vinsonii subspecies berkhoffii infection in the blood of immunocompetent persons who had arthropod and occupational animal exposure.

The Study

From November 2004 through June 2005, blood and serum samples from 42 persons were tested, and 14 completed a questionnaire, approved by the North Carolina State University Institutional Review Board. Age, sex, animal contact, history of bites, environment, outdoor activity, arthropod contact, travel, and medical history were surveyed. Bacterial isolation, PCR amplification, and cloning were performed by using previously described methods (–). Each blood sample was tested by PCR after direct DNA extraction, pre-enrichment culture for at least 7 days, and subculture onto a blood agar plate (Figure). An uninoculated, pre-enrichment culture was processed simultaneously as a control. Methods used for DNA extraction and conventional and real-time PCR targeting of the Bartonella 16S-23S intergenic spacer (ITS) region and heme-binding protein (Pap31) gene have been described (,). Conventional PCR amplicons were cloned with the pGEM-T Easy Vector System (Promega, Madison, WI, USA); sequencing was performed by Davis Sequencing, Inc. (Davis, CA, USA). Sequences were aligned and compared with GenBank sequences with AlignX software (Vector NTI Suite 6.0 (InforMax, Inc., Bethesda, MD, USA) (,). B. vinsonii subsp. berkhoffii, B. henselae, and B. quintana antibodies were determined by using a modification of a previously described immunofluorescence antibody assay (IFA) procedure ().
Figure

Diagram of sample processing and testing.

Diagram of sample processing and testing. Study participants included 12 women and 2 men, ranging in age from 30 to 53 years; all of them reported occupational animal contact for >10 years (Table). Most had daily contact with cats (13 persons) and dogs (12 persons). All participants reported animal bites or scratches (primarily from cats) and arthropod exposure, including fleas, ticks, biting flies, mosquitoes, lice, mites, or chiggers. All participants reported intermittent or chronic clinical symptoms, including fatigue, arthralgia, myalgia, headache, memory loss, ataxia, and paresthesia (Table). Illness was most frequently mild to moderate in severity, with a waxing and waning course, and all but 2 persons could perform occupational activities. Of the 14 participants, 9 had been evaluated by a cardiologist, 8 each by an infectious disease physician or a neurologist, and 5 each by an internist or a rheumatologist. Eleven participants had received antimicrobial drugs.
Table

Selected demographic, epidemiologic, and medical information reported by 14 immunocompetent persons infected with Bartonella henselae or B. vinsonii subsp. berkhoffii

Characteristic/symptomStudy participant no.
Total, 
N = 14
1234567891011121314
SexFFFFFFMFFFFFMF
Age, y5130484453503233485352395244
State of residenceNCNCNCCOVACANCVACACACACAVAMN
Occupational animal exposureVVtAAHRVVCRVtAVtAVtAVtAVtAVWBWB
Daily contact with dogs/catsY/YY/NN/YY/YY/YY/YY/YY/YY/YY/YY/YY/YN/YY/Y
Contact with fleas/ticks†2/13/34/44/43/32/33/32/24/42/43/13/2NA/34/3
Self-health assessment‡CICIIIIIIICICICICIIIIICIIICI
Fatigue+++++++++++++13
Joint pain++++++++++U10
Difficulty sleeping (insomnia)+++++++++9
Muscle pain++U+++U+++8
Difficulty remembering++++++++U8
Loss of sensation or numbness+++++++U7
Balance problems+++++++7
Headache+++++++U7
Tremors++++++6
Irritability++++++6
Bowel or bladder dysfunction++++++6
Eye pain+++++5
Blurred vision+++++5
Sleepiness+++++5
Syncope or fainting episodes+++++5
Shortness of breath+++++U5
Muscle weakness+++++U5

*F, female; M, male; NC, North Carolina, CO, Colorado, VA, Virginia; CA, California, MN, Minnesota; V, veterinarian; VtA, veterinary assistant; AHR, animal health researcher; CR, cattle rancher; WB, wildlife biologist; Y, yes; N, no, with respect to the study participant’s daily contact with dogs/cats; CI, chronically ill; II, infrequently ill; +, yes; –, no; blank, no answer reported; U, unknown.
†Reported as frequencies and defined as follows: 1, daily; 2, infrequently (weekly); 3, occasionally (monthly); 4, almost never (yearly).
‡Self-health assessment: As part of the questionnaire, study participants were asked to rate their own health status: healthy, infrequently ill, or chronically ill.

*F, female; M, male; NC, North Carolina, CO, Colorado, VA, Virginia; CA, California, MN, Minnesota; V, veterinarian; VtA, veterinary assistant; AHR, animal health researcher; CR, cattle rancher; WB, wildlife biologist; Y, yes; N, no, with respect to the study participant’s daily contact with dogs/cats; CI, chronically ill; II, infrequently ill; +, yes; –, no; blank, no answer reported; U, unknown.
†Reported as frequencies and defined as follows: 1, daily; 2, infrequently (weekly); 3, occasionally (monthly); 4, almost never (yearly).
‡Self-health assessment: As part of the questionnaire, study participants were asked to rate their own health status: healthy, infrequently ill, or chronically ill. When reciprocal titers of >64 were used, 8 persons were seroreactive to Bartonella antigens (Appendix Table). B. henselae or B. vinsonii subsp. berkhoffii was detected or isolated from all 14 participants. At the time of initial testing, Bartonella DNA was amplified directly from 3 blood samples, from 7 pre-enrichment liquid cultures, and from 4 subculture isolates (Appendix Table). For 5 persons, results of PCR and culture of initial samples were negative. Overall, Bartonella DNA was amplified from 11 (28%) of 40 extracted blood samples, 13 (33%) of 40 pre-enrichment cultures, and 5 isolates. For 7 persons, B. henselae DNA was amplified at multiple time points. Bartonella DNA was never amplified from any PCR control or uninoculated culture control. By using the ITS target region, 2 distinct B. henselae ITS and Pap31 strains were sequenced, B. henselae Houston I (HI) (GenBank NC-005956) and B. henselae San Antonio 2 (SA2) (GenBank AF369529). Within the noncoding ITS region, B. henselae SA2 strains have a 30-bp insertion (ATT GCT TCT AAA AAG ATT GCT TCT AAA AAG) located 518 bases downstream from the 16S gene. Only B. vinsonii subsp. berkhoffii types I and II were detected ().

Conclusions

Persistent human infection with B. bacilliformis and B. quintana has been previously documented, whereas infection with B. henselae (cat-scratch disease [CSD]) is generally considered self-limiting (,,). Recently, B. henselae DNA was amplified from the blood of a child 4 months after CSD diagnosis (). Our study indicates that B. henselae and B. vinsonii subsp. berkhoffii can induce occult infection in immunocompetent persons and that detection can be enhanced by combining PCR with pre-enrichment culture. Considering only the results from initial blood samples, PCR detected Bartonella DNA in 3 samples, all of which were subsequently PCR positive by subculture or enrichment culture. In samples from 5 persons, pre-enrichment was necessary, and in 5 other persons, sequential sampling was necessary to detect Bartonella infection. Intermittent bacteremia, as occurs in B. henselae–infected cats (), antimicrobial drug administration, low bacterial copy numbers, and low inoculum volume (1 mL) may have contributed to intermittent detection or inability to isolate Bartonella spp. from some participant samples. Although our approach is an improvement over historical isolation approaches, our results emphasize ongoing limitations associated with the detection of Bartonella infection. Obtaining stable Bartonella subcultures (n = 5 in this study) has proven problematic for other specialized laboratories that routinely culture for Bartonella spp. (,). To our knowledge, the B. vinsonii subsp. berkhoffii type II isolate described in our study is the only type II human isolate reported to date (). Various combinations of B. henselae and B. vinsonii subsp. berkhoffii strain types were detected in the same blood sample or sequential blood samples. The coexistence of B. henselae genetic variants has been described among primary patient isolates, which suggests that multiple genotypes may emerge within the same person (). Overall, 57% of persons tested were seroreactive to 1 or all 3 Bartonella test antigens. Previous reports from the United States identified a B. henselae seroprevalence of 3% in healthy blood donors and a cumulative seroprevalence of 7.1% to both B. henselae and B. quintana antigens in veterinary professionals (). In this and other studies, serologic test results did not correlate with PCR amplification or isolation results. Antigenic variability among B. henselae test strains can cause false-negative IFA results in persons with suspected CSD. Also B. henselae, B. quintana, or B. elizabethae antibodies were not detected in some persons with DNA evidence of active infection (,,). Animal contact, often to a wide spectrum of domestic and wild animal species, is an obvious consequence of the daily activities of the study population, which is biased by veterinary occupational exposure and by self-selection (volunteer bias). Cats are considered the primary reservoir host for B. henselae, whereas coyotes and foxes are considered reservoir hosts for B. vinsonii subsp. berkhoffii (,,). Detection of B. vinsonii subsp. berkhoffii in 4 of 5 Californian participants could be related to the high prevalence of bacteremic coyotes in this region as well as to the potential transmission by a tick vector (,). All 14 participants reported frequent arthropod exposure. Although Bartonella spp.transmission by ticks has not been proven, several recent studies have identified Bartonella DNA in questing ticks, ticks attached to animals, and ticks attached to humans (,,). Despite reporting chronic or episodic illness, most participants continued to effectively maintain daily professional and personal activities. The symptoms described in the study patients are very similar to those described in a community and hospital-based surveillance study of CSD patients, in whom CSD-associated arthropathy was an uncommon chronic syndrome affecting mostly young and middle-age women (). Our study was initiated to investigate the feasibility of combining PCR with pre-enrichment culture. Prospective studies, with appropriate controls, are needed to characterize the prevalence and clinical relevance of persistent Bartonella infection in immunocompetent persons.

Appendix Table

Serologic and PCR results from blood collected at multiple time points from 14 persons with frequent animal and arthropod contact
  15 in total

1.  Potential limitations of the 16S-23S rRNA intergenic region for molecular detection of Bartonella species.

Authors:  Ricardo G Maggi; Edward B Breitschwerdt
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

2.  Chronic Bartonella quintana bacteremia in homeless patients.

Authors:  P Brouqui; B Lascola; V Roux; D Raoult
Journal:  N Engl J Med       Date:  1999-01-21       Impact factor: 91.245

3.  Use of shell-vial cell culture assay for isolation of bacteria from clinical specimens: 13 years of experience.

Authors:  Frédérique Gouriet; Florence Fenollar; Jean-Yves Patrice; Michel Drancourt; Didier Raoult
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Cat-scratch disease-associated arthropathy.

Authors:  Michael Giladi; Eran Maman; Daphna Paran; Jacob Bickels; Doron Comaneshter; Boaz Avidor; Merav Varon-Graidy; Moshe Ephros; Shlomo Wientroub
Journal:  Arthritis Rheum       Date:  2005-11

5.  Clinical and pathologic evaluation of chronic Bartonella henselae or Bartonella clarridgeiae infection in cats.

Authors:  D L Kordick; T T Brown; K Shin; E B Breitschwerdt
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 6.  Factors associated with the rapid emergence of zoonotic Bartonella infections.

Authors:  Henri-Jean Boulouis; Chao-Chin Chang; Jennifer B Henn; Rickie W Kasten; Bruno B Chomel
Journal:  Vet Res       Date:  2005 May-Jun       Impact factor: 3.683

7.  Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998).

Authors:  B La Scola; D Raoult
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

8.  Isolation of Bartonella quintana from a woman and a cat following putative bite transmission.

Authors:  Edward B Breitschwerdt; Ricardo G Maggi; Betsy Sigmon; William L Nicholson
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

9.  Use of Bartonella antigens for serologic diagnosis of cat-scratch disease at a national referral center.

Authors:  M J Dalton; L E Robinson; J Cooper; R L Regnery; J G Olson; J E Childs
Journal:  Arch Intern Med       Date:  1995 Aug 7-21

Review 10.  Clinical impact of persistent Bartonella bacteremia in humans and animals.

Authors:  Bruno B Chomel; Rickie W Kasten; Jane E Sykes; Henri-Jean Boulouis; Edward B Breitschwerdt
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

View more
  47 in total

1.  Bartonella clarridgeiae bacteremia detected in an asymptomatic blood donor.

Authors:  Gislaine Vieira-Damiani; Pedro Paulo Vissotto de Paiva Diniz; Luiza Helena Urso Pitassi; Stanley Sowy; Diana Gerardi Scorpio; Bruno Grosselli Lania; Marina Rovani Drummond; Tânia Cristina Benetti Soares; Maria de Lourdes Barjas-Castro; Edward B Breitschwerdt; William L Nicholson; Paulo Eduardo Neves Ferreira Velho
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

2.  Combining culture techniques for Bartonella: the best of both worlds.

Authors:  Tarah Lynch; Jennifer Iverson; Michael Kosoy
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

3.  Comparative activity of pradofloxacin, enrofloxacin, and azithromycin against Bartonella henselae isolates collected from cats and a human.

Authors:  Silpak Biswas; Ricardo G Maggi; Mark G Papich; Daniel Keil; Edward B Breitschwerdt
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

4.  Molecular characterization of Bartonella vinsonii subsp. berkhoffii genotype III.

Authors:  Maria B Cadenas; Julie Bradley; Ricardo G Maggi; Matt Takara; Barbara C Hegarty; Edward B Breitschwerdt
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

5.  Ecological and Socioeconomic Factors Associated with Bartonella henselae Exposure in Dogs Tested for Vector-Borne Diseases in North Carolina.

Authors:  Erin W Lashnits; Daniel E Dawson; Edward Breitschwerdt; Cristina Lanzas
Journal:  Vector Borne Zoonotic Dis       Date:  2019-05-21       Impact factor: 2.133

6.  Molecular evidence of perinatal transmission of Bartonella vinsonii subsp. berkhoffii and Bartonella henselae to a child.

Authors:  Edward B Breitschwerdt; Ricardo G Maggi; Peter Farmer; Patricia E Mascarelli
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

7.  Spontaneous onset of complex regional pain syndrome Type I in a woman infected with Bartonella koehlerae.

Authors:  Cristina Pérez Vera; Ricardo G Maggi; Christopher W Woods; Patricia E Mascarelli; Edward B Breitschwerdt
Journal:  Med Microbiol Immunol       Date:  2013-12-10       Impact factor: 3.402

8.  Human isolates of Bartonella tamiae induce pathology in experimentally inoculated immunocompetent mice.

Authors:  Leah Colton; Nordin Zeidner; Tarah Lynch; Michael Y Kosoy
Journal:  BMC Infect Dis       Date:  2010-07-30       Impact factor: 3.090

9.  Transmission of feline calicivirus via the cat flea (Ctenocephalides felis).

Authors:  N Mencke; M Vobis; H Mehlhorn; J D Haese; M Rehagen; S Mangold-Gehring; U Truyen
Journal:  Parasitol Res       Date:  2009-03-10       Impact factor: 2.289

10.  Bartonella DNA in dog saliva.

Authors:  Ashlee W Duncan; Ricardo G Maggi; Edward B Breitschwerdt
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.